Bridgeway Capital Management’s TELA Bio TELA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112K | Hold |
57,500
| – | – | ﹤0.01% | 1052 |
|
|
2025
Q1 | $70.2K | Buy |
57,500
+6,800
| +13% | +$8.3K | ﹤0.01% | 1093 |
|
|
2024
Q4 | $153K | Sell |
50,700
-52,300
| -51% | -$158K | ﹤0.01% | 1055 |
|
|
2024
Q3 | $261K | Buy |
103,000
+50,000
| +94% | +$127K | 0.01% | 1006 |
|
|
2024
Q2 | $249K | Buy |
53,000
+16,000
| +43% | +$75.2K | 0.01% | 1005 |
|
|
2024
Q1 | $210K | Sell |
37,000
-42,000
| -53% | -$238K | ﹤0.01% | 1102 |
|
|
2023
Q4 | $523K | Buy |
79,000
+20,000
| +34% | +$132K | 0.01% | 929 |
|
|
2023
Q3 | $472K | Hold |
59,000
| – | – | 0.01% | 893 |
|
|
2023
Q2 | $598K | Hold |
59,000
| – | – | 0.01% | 857 |
|
|
2023
Q1 | $628K | Hold |
59,000
| – | – | 0.02% | 830 |
|
|
2022
Q4 | $679K | Hold |
59,000
| – | – | 0.02% | 821 |
|
|
2022
Q3 | $503K | Sell |
59,000
-18,000
| -23% | -$153K | 0.01% | 895 |
|
|
2022
Q2 | $547K | Buy |
77,000
+15,000
| +24% | +$107K | 0.01% | 861 |
|
|
2022
Q1 | $721K | Hold |
62,000
| – | – | 0.01% | 857 |
|
|
2021
Q4 | $794K | Hold |
62,000
| – | – | 0.01% | 837 |
|
|
2021
Q3 | $847K | Sell |
62,000
-25,000
| -29% | -$342K | 0.02% | 870 |
|
|
2021
Q2 | $1.4M | Buy |
87,000
+41,300
| +90% | +$666K | 0.03% | 741 |
|
|
2021
Q1 | $681K | Buy |
+45,700
| New | +$681K | 0.01% | 1009 |
|
|
2020
Q3 | – | Sell |
-18,700
| Closed | -$242K | – | 1357 |
|
|
2020
Q2 | $242K | Buy |
18,700
+8,700
| +87% | +$113K | ﹤0.01% | 1099 |
|
|
2020
Q1 | $78K | Buy |
+10,000
| New | +$78K | ﹤0.01% | 1199 |
|